Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and-12, in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 304, Issue 6, 2013, Pages

  Pyla, Rajkumar ^a,b   Poulose, Ninu ^a,b   Jun, John Y ^d   Segar, Lakshman ^a,b,c,d  

^a UNIVERSITY OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Differentiated phenotype; Human aortic smooth muscle cells; mRNA expression; Proliferative phenotype; Protein expression

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 10; GLUCOSE TRANSPORTER 12; GLUCOSE TRANSPORTER 9; MESSENGER RNA; UNCLASSIFIED DRUG; ISOPROTEIN; SLC2A1 PROTEIN, HUMAN; SLC2A10 PROTEIN, HUMAN; SLC2A12 PROTEIN, HUMAN; SLC2A9 PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; AORTA; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; GENETICS; METABOLISM;

AORTA; CELL DIFFERENTIATION; CELL PROLIFERATION; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE; PROTEIN ISOFORMS;

MLCS; MLOWN;

EID: 84877307244     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00275.2012     Document Type: Article

References (59)

1. Adhikari N, Basi DL, Carlson M, Mariash A, Hong Z, Lehman U, Mullegama S, Weir EK, Hall JL. Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injury. Arterioscler Thromb Vasc Biol 31: 86-94, 2011.
2. Aerni-Flessner L, Abi-Jaoude M, Koenig A, Payne M, Hruz PW. GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts ex-pressed in the murine left ventricle. Cardiovasc Diabetol 11: 63, 2012.
3. Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, Jin CJ, Srivastava S, Kitamura K, Hisatome I, Endou H, Sakurai H. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem 283: 26834-26838, 2008.
4. Asano T, Katagiri H, Takata K, Lin JL, Ishihara H, Inukai K, Tsukuda K, Kikuchi M, Hirano H, Yazaki Y, Oka Y. The role of N-glycosylation of GLUT1 for glucose transport activity. J Biol Chem 266: 24632-24636, 1991.
5. Atkins KB, Johns D, Watts S, Clinton Webb R, Brosius FC 3rd. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension. J Hypertens 19: 1581-1587, 2001.
6. Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose trans-porter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 279: 16229-16236, 2004.
7. Buller CL, Loberg RD, Fan MH, Zhu Q, Park JL, Vesely E, Inoki K, Guan KL, Brosius FC 3rd. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am J Physiol Cell Physiol 295: C836-C843, 2008.
8. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 38: 452-457, 2006.
9. Cushman SW, Simpson IA. Integral membrane protein translocations in the mechanism of insulin action. Biochem Soc Symp 50: 127-149, 1985.
10. Daugaard JR, Richter EA. Relationship between muscle fibre composi-tion, glucose transporter protein 4 and exercise training: possible conse-quences in non-insulin-dependent diabetes mellitus. Acta Physiol Scand 171: 267-276, 2001.
11. Devraj K, Geguchadze R, Klinger ME, Freeman WM, Mokashi A, Hawkins RA, Simpson IA. Improved membrane protein solubilization and clean-up for optimum two-dimensional electrophoresis utilizing GLUT-1 as a classic integral membrane protein. J Neurosci Methods 184: 119-123, 2009.
12. Doblado M, Moley KH. Facilitative glucose transporter 9, a unique hexose and urate transporter. Am J Physiol Endocrinol Metab 297: E831-E835, 2009.
13. Dugani CB, Randhawa VK, Cheng AW, Patel N, Klip A. Selective regulation of the perinuclear distribution of glucose transporter 4 (GLUT4) by insulin signals in muscle cells. Eur J Cell Biol 87: 337-351, 2008.
14. Evans SA, Doblado M, Chi MM, Corbett JA, Moley KH. Facilitative glucose transporter 9 expression affects glucose sensing in pancreatic beta-cells. Endocrinology 150: 5302-5310, 2009.
15. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 28: 1601-1613, 2006.
16. Frolova A, Flessner L, Chi M, Kim ST, Foyouzi-Yousefi N, Moley KH. Facilitative glucose transporter type 1 is differentially regulated by pro-gesterone and estrogen in murine and human endometrial stromal cells. Endocrinology 150: 1512-1520, 2009.
17. Gaudreault N, Scriven DR, Laher I, Moore ED. Subcellular character-ization of glucose uptake in coronary endothelial cells. Microvasc Res 75: 73-82, 2008.
18. Grempler R, Augustin R, Froehner S, Hildebrandt T, Simon E, Mark M, Eickelmann P. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. FEBS Lett 586: 248-253, 2012.
19. Hall JL, Chatham JC, Eldar-Finkelman H, Gibbons GH. Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta. Diabetes 50: 1171-1179, 2001.
20. Hall JL, Gibbons GH, Chatham JC. IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells. Am J Physiol Endocrinol Metab 283: E465-E471, 2002.
21. Han M, Wen JK, Zheng B, Cheng Y, Zhang C. Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells. Am J Physiol Cell Physiol 291: C50-C58, 2006.
22. Hastings NE, Simmers MB, McDonald OG, Wamhoff BR, Blackman BR. Atherosclerosis-prone hemodynamics differentially regulates endo-thelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol 293: C1824-C1833, 2007.
23. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190, 2003.
24. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 18: 247-256, 2001.
25. Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, King GL. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42: 80-89, 1993.
26. Karnieli E, Zarnowski MJ, Hissin PJ, Simpson IA, Salans LB, Cush-man SW. Insulin-stimulated translocation of glucose transport systems in the isolated rat adipose cell. Time course, reversal, insulin concentration dependency, and relationship to glucose transport activity. J Biol Chem 256: 4772-4777, 1981.
27. Keembiyehetty C, Augustin R, Carayannopoulos MO, Steer S, Man-olescu A, Cheeseman CI, Moley KH. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol 20: 686-697, 2006.
28. Lee YC, Huang HY, Chang CJ, Cheng CH, Chen YT. Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome. Hum Mol Genet 19: 3721-3733, 2010.
29. Li Q, Manolescu A, Ritzel M, Yao S, Slugoski M, Young JD, Chen XZ, Cheeseman CI. Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine. Am J Physiol Gastro-intest Liver Physiol 287: G236-G242, 2004.
30. Liu J, Wang R, Desai K, Wu L. Upregulation of aldolase B and overproduction of methylglyoxal in vascular tissues from rats with meta-bolic syndrome. Cardiovasc Res 92: 494-503, 2011.
31. Low BC, Ross IK, Grigor MR. Angiotensin II stimulates glucose transport activity in cultured vascular smooth muscle cells. J Biol Chem 267: 20740-20745, 1992.
32. Madsen CS, Regan CP, Owens GK. Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells. J Biol Chem 272: 29842-29851, 1997.
33. Maher F, Vannucci SJ, Simpson IA. Glucose transporter proteins in brain. FASEB J 8: 1003-1011, 1994.
34. Marcus RG, England R, Nguyen K, Charron MJ, Briggs JP, Brosius FC 3rd. Altered renal expression of the insulin-responsive glucose trans-porter GLUT4 in experimental diabetes mellitus. Am J Physiol Renal Fluid Electrolyte Physiol 267: F816-F824, 1994.
35. McVie-Wylie AJ, Lamson DR, Chen YT. Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), local-ized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility. Genomics 72: 113-117, 2001.
36. Mitsumoto Y, Klip A. Development regulation of the subcellular distri-bution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem 267: 4957-4962, 1992.
37. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004.
38. Park JL, Loberg RD, Duquaine D, Zhang H, Deo BK, Ardanaz N, Coyle J, Atkins KB, Schin M, Charron MJ, Kumagai AK, Pagano PJ, Brosius FC 3rd. GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta. Arterioscler Thromb Vasc Biol 25: 1596-1602, 2005.
39. Pette D. Historical Perspectives: plasticity of mammalian skeletal muscle. J Appl Physiol 90: 1119-1124, 2001.
40. Phay JE, Hussain HB, Moley JF. Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 66: 217-220, 2000.
41. Purcell SH, Aerni-Flessner LB, Willcockson AR, Diggs-Andrews KA, Fisher SJ, Moley KH. Improved insulin sensitivity by GLUT12 overex-pression in mice. Diabetes 60: 1478-1482, 2011.
42. Rand EB, Depaoli AM, Davidson NO, Bell GI, Burant CF. Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5. Am J Physiol Gastrointest Liver Physiol 264: G1169-G1176, 1993.
43. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 266: 8604-8608, 1991.
44. Renard CB, Bornfeldt KE. Human arterial smooth muscle cells rapidly deplete cell culture media of glucose. Diabetologia 44: 1067-1068, 2001.
45. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
46. Ruan XZ, Moorhead JF, Tao JL, Ma KL, Wheeler DC, Powis SH, Varghese Z. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 26: 1150-1155, 2006.
47. Santalucia T, Boheler KR, Brand NJ, Sahye U, Fandos C, Vinals F, Ferre J, Testar X, Palacin M, Zorzano A. Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle. J Biol Chem 274: 17626-17634, 1999.
48. Schmittgen TD, Zakrajsek BA. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 46: 69-81, 2000.
49. Solway J, Forsythe SM, Halayko AJ, Vieira JE, Hershenson MB, Camoretti-Mercado B. Transcriptional regulation of smooth muscle contractile apparatus expression. Am J Respir Crit Care Med 158: S100-108, 1998.
50. Stuart CA, Howell ME, Zhang Y, Yin D. Insulin-stimulated transloca-tion of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. J Clin Endocrinol Metab 94: 3535-3542, 2009.
51. Stuart CA, Yin D, Howell ME, Dykes RJ, Laffan JJ, Ferrando AA. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predom-inate in human muscle. Am J Physiol Endocrinol Metab 291: E1067-E1073, 2006.
52. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 50: 851-860, 2001.
53. Uldry M, Thorens B. The SLC2 family of facilitated hexose and polyol transporters. Pflügers Arch 447: 480-489, 2004.
54. Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21: 2-21, 1997.
55. Vinals F, Fandos C, Santalucia T, Ferre J, Testar X, Palacin M, Zorzano A. Myogenesis and MyoD down-regulate Sp1. A mechanism for the repression of GLUT1 during muscle cell differentiation. J Biol Chem 272: 12913-12921, 1997.
56. Werle M, Kreuzer J, Hofele J, Elsasser A, Ackermann C, Katus HA, Vogt AM. Metabolic control analysis of the Warburg-effect in prolifer-ating vascular smooth muscle cells. J Biomed Sci 12: 827-834, 2005.
57. Wood IS, Wang B, Lorente-Cebrian S, Trayhurn P. Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-de-oxy-D-glucose uptake in human adipocytes. Biochem Biophys Res Com-mun 361: 468-473, 2007.
58. Wright EM, Loo DD, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev 91: 733-794, 2011.
59. Zhao Y, Biswas SK, McNulty PH, Kozak M, Jun JY, Segar L. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates. Am J Physiol Cell Physiol 300: C1375-C1385, 2011.